Who Buys Fluticasone from India — 664 Importers Behind a $203.0M Market
India's fluticasone import market is served by 664 active buyers who collectively imported $203.0M across 9,009 shipments. MYLAN IRELAND LTD (NETHERLANDS) leads with a 24.6% market share, followed by MYLAN IRELAND LIMITED and PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR. The top 5 buyers together control 43.8% of total import value, reflecting a moderately competitive buyer landscape.
Top Fluticasone Importers — Ranked by Import Value
MYLAN IRELAND LTD (NETHERLANDS) is the leading fluticasone importer from India, holding a 24.6% share of the $203.0M market across 9,009 shipments from 664 buyers. The top 5 buyers — MYLAN IRELAND LTD (NETHERLANDS), MYLAN IRELAND LIMITED (NETHERLANDS), PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR (TURKEY), APOTEX INC (CANADA), CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) — collectively control 43.8% of total import value.
Top Fluticasone Buyers & Importers
Ranked by import value · 664 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | MYLAN IRELAND LTDNETHERLANDS DYMISTA NASAL SUSPENSION);DYMISTA TRADE PACK -SALPLUSF INHALER 250/25APO-FLUTICASONE HFA 250MCG/MD(WITH POUCH | $50.0M | 5 | 24.6% |
| 2 | MYLAN IRELAND LIMITEDNETHERLANDS DYMISTA NASAL SUSPENSION);DYMISTA TRADE PACK -SALPLUSF INHALER 250/25APO-FLUTICASONE HFA 250MCG/MD(WITH POUCH | $16.9M | 5 | 8.3% |
| 3 | PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARTURKEY SEROFLO 250 HFA INHALERFLOHALE 250 HFA INHALER FLUTICASONE PROSEROFLO 125 HFA INHALER | $8.7M | 5 | 4.3% |
| 4 | APOTEX INCCANADA APO-FLUTICASONE HFA 250MCG/MD(WITH POUCHDYMISTA NASAL SUSPENSION);DYMISTA TRADE PACK -APO-FLUTICASONE HFA 125MCG/MD(FLUTICASON | $7.9M | 5 | 3.9% |
| 5 | CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES SALPLUSF INHALER 250/25DYMISTA TRADE PACK DYMISTA TRADE PACK - 17ML/ 120 SPRAYS -SALPLUSF INHALER 250/25 (FLUTICASONE PRO | $5.5M | 5 | 2.7% |
| 6 | MYLAN AUSTRALIAAUSTRALIA DYMISTA NASAL SUSPENSION);DYMISTA TRADE PACK -SALPLUSF INHALER 250/25APO-FLUTICASONE HFA 250MCG/MD(WITH POUCH | $5.0M | 5 | 2.5% |
| 7 | MEDPRO PHARMACEUTICA PTY LTDSOUTH AFRICA FLOMIST NASAL SPRAY (FLUTICASONE PROPIONFLOMIST NASAL SPRAY 1 X 120 MDFLOMIST NASAL SPRAY | $3.9M | 5 | 1.9% |
| 8 | SALUTAS PHARMA GMBHGERMANY | $3.5M | 5 | 1.7% |
| 9 | SANDOZ PTY LTDAUSTRALIA SALPLUSF INHALER 250/25SALPLUSF INHALER 250/25 (FLUTICASONE PRO | $3.2M | 5 | 1.6% |
| 10 | VIATRIS PTY LTDAUSTRALIA SALPLUSF INHALER 250/25DYMISTA TRADE PACK DYMISTA TRADE PACK - 17ML/ 120 SPRAYS -SEROFLO 250 HFA INHALER | $2.7M | 5 | 1.3% |
| 11 | CIPLA AUSTRALIA PTY LTD,AUSTRALIA SALPLUSF INHALER 250/25DYMISTA TRADE PACK DYMISTA TRADE PACK - 17ML/ 120 SPRAYS -SALPLUSF INHALER 250/25 (FLUTICASONE PRO | $2.5M | 5 | 1.2% |
| 12 | ALLOGA UK LTDUNITED KINGDOM | $2.3M | 5 | 1.2% |
| 13 | CIPLA MAROCMOROCCO SALPLUSF INHALER 250/25DYMISTA TRADE PACK DYMISTA TRADE PACK - 17ML/ 120 SPRAYS -SALPLUSF INHALER 250/25 (FLUTICASONE PRO | $2.3M | 5 | 1.1% |
| 14 | SANDOZ PTY LTD. SANDOZAUSTRALIA SALPLUSF INHALER 250/25SALPLUSF INHALER 250/25 (FLUTICASONE PRO | $2.2M | 5 | 1.1% |
| 15 | MEDPRO PHARMACEUTICA PTY LIMITEDSOUTH AFRICA FLOMIST NASAL SPRAY (FLUTICASONE PROPIONFLOMIST NASAL SPRAY 1 X 120 MDFLOMIST NASAL SPRAY | $1.9M | 5 | 0.9% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Fluticasone — and from which countries?
Flow of Fluticasone exports from India: each country's share and the named importers behind the numbers
Fluticasone — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Netherlands
Netherlands emerges as the first largest importing country, achieving a total trade value of $69.4M through 485 shipments. This represents a market share of 34.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• MYLAN IRELAND LTD - $50.0M (72.0% of country's total business)
• MYLAN IRELAND LIMITED - $16.9M (24.3% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $143.1K, indicating premium pricing strategy compared to the market average of $22.5K.
Netherlands is a key market for Fluticasone imports, representing 34.2% of total trade value.
2Australia
Australia emerges as the second largest importing country, achieving a total trade value of $20.4M through 99 shipments. This represents a market share of 10.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• MYLAN AUSTRALIA - $5.0M (24.4% of country's total business)
• SANDOZ PTY LTD - $3.2M (15.8% of country's total business)
• VIATRIS PTY LTD - $2.7M (13.1% of country's total business)
• CIPLA AUSTRALIA PTY LTD, - $2.5M (12.0% of country's total business)
• SANDOZ PTY LTD. SANDOZ - $2.2M (10.7% of country's total business)
• Rest of Australia's importers - $4.9M (23.9% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $206.4K, indicating premium pricing strategy compared to the market average of $22.5K.
Australia is a key market for Fluticasone imports, representing 10.1% of total trade value.
3Canada
Canada emerges as the third largest importing country, achieving a total trade value of $11.9M through 182 shipments. This represents a market share of 5.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• APOTEX INC - $7.9M (66.0% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $65.4K, indicating premium pricing strategy compared to the market average of $22.5K.
Canada is a key market for Fluticasone imports, representing 5.9% of total trade value.
4South Africa
South Africa emerges as the fourth largest importing country, achieving a total trade value of $10.9M through 145 shipments. This represents a market share of 5.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: South Africa has a diverse importer base, with their top importers including:
• MEDPRO PHARMACEUTICA PTY LTD - $3.9M (36.1% of country's total business)
• MEDPRO PHARMACEUTICA PTY LIMITED - $1.9M (17.4% of country's total business)
• MEDPRO PHARMACEUTICA (PTY) LTD - $1.8M (16.9% of country's total business)
Key Insight: South Africa demonstrates strong market positioning with an average shipment value of $75.4K, indicating premium pricing strategy compared to the market average of $22.5K.
South Africa is a key market for Fluticasone imports, representing 5.4% of total trade value.
5Turkey
Turkey emerges as the fifth largest importing country, achieving a total trade value of $8.5M through 96 shipments. This represents a market share of 4.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Turkey has a diverse importer base, with their top importers including:
• PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR - $8.7M (101.9% of country's total business)
Key Insight: Turkey demonstrates strong market positioning with an average shipment value of $88.5K, indicating premium pricing strategy compared to the market average of $22.5K.
Turkey is a key market for Fluticasone imports, representing 4.2% of total trade value.
Buyer Segment Analysis
TransData Nexus Fluticasone buyer market intelligence
1Buyer Segment Analysis
The 664 buyers of Fluticasone from India can be categorized into several segments:
1. Pharmaceutical Companies: Entities like MYLAN IRELAND LTD and APOTEX INC are pharmaceutical manufacturers that procure Fluticasone as an active pharmaceutical ingredient (API) for their formulations. Their purchasing patterns typically involve large, consistent orders to meet production demands.
2. Distributors: Companies such as PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR in Turkey act as intermediaries, purchasing Fluticasone in bulk and supplying it to various healthcare providers. Their orders are substantial and regular, aligning with market demand.
3. Contract Manufacturers: Entities like CIPLA USA INC UPS SUPPLY CHAIN SOLU procure Fluticasone to manufacture products on behalf of other companies. Their purchasing behavior is project-based, with volumes varying according to contractual obligations.
4. Re-exporters: Companies such as MYLAN AUSTRALIA and VIATRIS PTY LTD in Australia may import Fluticasone for re-export to other markets. Their order sizes and frequencies depend on the demand in their target export destinations.
Each segment's procurement strategies are influenced by factors such as regulatory requirements, market demand, and supply chain logistics.
Country-Specific Import Regulations
TransData Nexus Fluticasone buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Fluticasone are as follows:
1. Netherlands:
2. Australia:
3. Canada:
4. South Africa:
5. Turkey:
Demand Drivers & Market Opportunity
TransData Nexus Fluticasone buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Fluticasone in importing countries is driven by several factors:
1. Disease Prevalence: Fluticasone is primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD). According to the World Health Organization (WHO), as of 2025, approximately 262 million people worldwide suffer from asthma, and 212 million from COPD, indicating a substantial patient base requiring inhaled corticosteroids like Fluticasone.
2. Government Healthcare Programs: Many countries have implemented programs to improve access to essential medicines. For instance, the WHO's Model List of Essential Medicines includes Fluticasone, encouraging its procurement and distribution in member countries.
3. Universal Health Coverage Expansion: Countries expanding their universal health coverage often include essential respiratory medicines in their formularies, increasing demand for Fluticasone.
4. Tender-Based Purchasing: Public sector procurement through competitive tendering processes ensures the availability of cost-effective medicines. The WHO recommends tendering as a method to improve affordability and availability of essential medicines.
With 664 buyers across 123 countries, the global reach and consistent demand for Fluticasone underscore its critical role in respiratory disease management and present significant market opportunities for suppliers.
Common Questions — Fluticasone Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest fluticasone buyer importing from India?
Based on import volume and value, MYLAN IRELAND LTD (NETHERLANDS) leads with $50.0M in imports and a 24.6% market share — the highest of any single fluticasone importer. MYLAN IRELAND LIMITED (NETHERLANDS) and PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR (TURKEY) are the next largest buyers.
QHow many companies buy fluticasone from India?
There are 664 active fluticasone buyers importing from India, with a combined market of $203.0M across 9,009 shipments to 123 countries. The top 5 buyers hold 43.8% of total import value, while the remaining 659 buyers handle the other 56.2%.
QWhich countries import the most fluticasone from India?
The top importing countries for fluticasone from India are Netherlands (34.2%), Australia (10.1%), Canada (5.9%), South Africa (5.4%), Turkey (4.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of fluticasone, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for fluticasone from India?
The average import transaction value for fluticasone from India is $22.5K, with an average unit price of $17.14 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Fluticasone buyer market intelligence
1Buyer Segment Analysis
The 664 buyers of Fluticasone from India can be categorized into several segments:
1. Pharmaceutical Companies: Entities like MYLAN IRELAND LTD and APOTEX INC are pharmaceutical manufacturers that procure Fluticasone as an active pharmaceutical ingredient (API) for their formulations. Their purchasing patterns typically involve large, consistent orders to meet production demands.
2. Distributors: Companies such as PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR in Turkey act as intermediaries, purchasing Fluticasone in bulk and supplying it to various healthcare providers. Their orders are substantial and regular, aligning with market demand.
3. Contract Manufacturers: Entities like CIPLA USA INC UPS SUPPLY CHAIN SOLU procure Fluticasone to manufacture products on behalf of other companies. Their purchasing behavior is project-based, with volumes varying according to contractual obligations.
4. Re-exporters: Companies such as MYLAN AUSTRALIA and VIATRIS PTY LTD in Australia may import Fluticasone for re-export to other markets. Their order sizes and frequencies depend on the demand in their target export destinations.
Each segment's procurement strategies are influenced by factors such as regulatory requirements, market demand, and supply chain logistics.
Country-Specific Import Regulations
TransData Nexus Fluticasone buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Fluticasone are as follows:
1. Netherlands:
2. Australia:
3. Canada:
4. South Africa:
5. Turkey:
Demand Drivers & Market Opportunity
TransData Nexus Fluticasone buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Fluticasone in importing countries is driven by several factors:
1. Disease Prevalence: Fluticasone is primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD). According to the World Health Organization (WHO), as of 2025, approximately 262 million people worldwide suffer from asthma, and 212 million from COPD, indicating a substantial patient base requiring inhaled corticosteroids like Fluticasone.
2. Government Healthcare Programs: Many countries have implemented programs to improve access to essential medicines. For instance, the WHO's Model List of Essential Medicines includes Fluticasone, encouraging its procurement and distribution in member countries.
3. Universal Health Coverage Expansion: Countries expanding their universal health coverage often include essential respiratory medicines in their formularies, increasing demand for Fluticasone.
4. Tender-Based Purchasing: Public sector procurement through competitive tendering processes ensures the availability of cost-effective medicines. The WHO recommends tendering as a method to improve affordability and availability of essential medicines.
With 664 buyers across 123 countries, the global reach and consistent demand for Fluticasone underscore its critical role in respiratory disease management and present significant market opportunities for suppliers.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 664 global importers of Fluticasone identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 9,009 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 123 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9,009 Verified Shipments
664 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists